Samuel Lai

University of North Carolina at Chapel Hill

NIH Rank #6701
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$1.8M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#6,701
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.8M across 4 grants · National rank #6701.

Top grants by award amount

Samuel Lai's NIH grant portfolio, ranked by award amount.

  • 5R01HD101344-05R01
    Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception
    $728.6K
    award amount
  • 5R01AI165853-03R01
    Engineered “muco-trapping” antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
    $629.2K
    award amount
  • 1R21AI180822-01R21
    In vivo engineering of chimeric antibody reprogrammed (CAR) B cells with fully tunable antibody response
    $233.3K
    award amount
  • 5R21CA273983-02R21
    Engineering Siglec15/TGF-beta targeted bispecific antibodies that modulate the tumor microenvironment and enhances T-cell immunotherapy against pancreatic cancer
    $169.6K
    award amount

Affiliations

Institutions that have administered grants for Samuel Lai.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of North Carolina at Chapel Hill
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6701
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions